Bruderman Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-125
| Closed | -$11K | – | 577 |
|
|
2019
Q1 | $11K | Hold |
125
| – | – | ﹤0.01% | 436 |
|
|
2018
Q4 | $9K | Sell |
125
-56,648
| -100% | -$4.08M | ﹤0.01% | 447 |
|
|
2018
Q3 | $5.44M | Buy |
56,773
+7,509
| +15% | +$720K | 1.25% | 30 |
|
|
2018
Q2 | $4.69M | Buy |
49,264
+5,218
| +12% | +$497K | 1.14% | 30 |
|
|
2018
Q1 | $3.86M | Buy |
44,046
+4,044
| +10% | +$355K | 0.93% | 36 |
|
|
2017
Q4 | $3.4M | Buy |
40,002
+4,167
| +12% | +$354K | 0.86% | 38 |
|
|
2017
Q3 | $3.1M | Buy |
35,835
+5,177
| +17% | +$448K | 0.8% | 36 |
|
|
2017
Q2 | $2.37M | Buy |
30,658
+3,980
| +15% | +$307K | 0.63% | 42 |
|
|
2017
Q1 | $1.85M | Buy |
26,678
+1,793
| +7% | +$124K | 0.53% | 47 |
|
|
2016
Q4 | $1.47M | Buy |
+24,885
| New | +$1.47M | 0.44% | 53 |
|
|
2015
Q4 | – | Sell |
-205
| Closed | -$13K | – | 435 |
|
|
2015
Q3 | $13K | Buy |
+205
| New | +$13K | 0.01% | 322 |
|